Healthcare & Pharma

The global Pre-Filled Syringes market was valued at US$3,944.2 million in 2022 and is projected to grow at a CAGR of 8.41% during the forecast period 2023-2033.

The global Fill-Finish Manufacturing market was valued at US$9,383.0 million in 2022 and is projected to grow at a CAGR of 9.2% during the forecast period 2023-2033.

The global Gynaecology Drugs market was valued at US$43,561 million in 2023 and is projected to grow at a CAGR of 5.1% during the forecast period 2023-2033.

The global Surgical Robots market was valued at US$8.40 billion in 2022 and is projected to grow at a CAGR of 19% during the forecast period 2023-2033.

The antibiotics market was valued at US$44,567.3 million in 2022 and is projected to grow at a CAGR of 4.15% during the forecast period 2023-2033.

The global Clinical Trial Supplies market was valued at US$ 2,617.7 million in 2022 and is projected to grow at a CAGR of 9.32% during the forecast period 2023-2033.

The global Meningococcal Vaccines market was valued at US$3,268.6 million in 2022 and is projected to grow at a CAGR of 6.32% during the forecast period 2023-2033.

The global Human Microbiome market was valued at US$186.8 million in 2022 and is projected to grow at a CAGR of 25% during the forecast period 2023-2033.

The global Allergic Rhinitis Drugs market was valued at US$12,025.2 million in 2022 and is projected to grow at a CAGR of 3.78% during the forecast period 2023-2033.

The global Women’s Health market was valued at US$36,567.3 million in 2022 and is projected to grow at a CAGR of 4.1% during the forecast period 2023-2033.

The global Biodefence market was valued at US$14,675.0 million in 2022 and is projected to grow at a CAGR of 7.78% during the forecast period 2023-2033.

The global Neurotech Devices market was valued at US$11,582.1 million in 2022 and is projected to grow at a CAGR of 13.78% during the forecast period 2023-2033.

The global Wearable Brain Devices market was valued at US$276.0 million in 2022 and is projected to grow at a CAGR of 11.4% during the forecast period 2023-2033.

The global Asthma & COPD Therapies market is estimated to be valued at US$47.85 billion in 2023 and is projected to grow at a CAGR of 7.31% during the forecast period 2023-2033.

The global Point of Care Diagnostics market is estimated to be valued at US$43.05 billion in 2023 and is projected to grow at a CAGR of 8.8% during the forecast period 2023-2033.

The global Infectious Disease Diagnostics market was valued at US$ 28,272.2 million in 2021 and is projected to grow at a CAGR of 6.61% during the forecast period 2022-2032.

The global Monoclonal Antibody Discovery and Analysis market was valued at US$5,234 million in 2021 and is projected to grow at a CAGR of 9.0% during the forecast period 2022-2032.

The global CMO of Sterile Injectable Drugs market was valued at US$19,090.4 million in 2021 and is projected to grow at a CAGR of 9.10% during the forecast period 2022-2032.

The global Neurostimulation Devices market is valued at US$8,127.3 million in 2022 and is projected to grow at a CAGR of 11.35% during the forecast period 2023-2033.

The global Cardiovascular Devices market is estimated to be valued at US$59.57 billion in 2022 and is projected to grow at a CAGR of 6.92% during the forecast period 2023-2033.